Compare NRXP & JELD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRXP | JELD |
|---|---|---|
| Founded | 2015 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Forest Products |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 152.5M |
| IPO Year | 2017 | 2016 |
| Metric | NRXP | JELD |
|---|---|---|
| Price | $3.47 | $2.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $38.25 | $3.43 |
| AVG Volume (30 Days) | 790.1K | ★ 1.7M |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 69.70 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,225,000.00 | ★ $3,211,181,000.00 |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | $2.06 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.65 | $0.93 |
| 52 Week High | $5.06 | $6.51 |
| Indicator | NRXP | JELD |
|---|---|---|
| Relative Strength Index (RSI) | 49.32 | 54.83 |
| Support Level | $3.45 | $1.10 |
| Resistance Level | $3.62 | $3.12 |
| Average True Range (ATR) | 0.17 | 0.22 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 46.67 | 46.75 |
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
JELD-WEN Holding Inc is engaged in door and window manufacturing. The company designs, produces, and distributes interior and exterior building products, offering a selection of doors, windows, walls, and related products. The products are used in the new construction of residential and non-residential buildings. The firm's operating segments are North America, and Europe. It generates a majority of its revenue from North America.